Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Quick Order
Products
Antibodies
ELISA and Assay Kits
Research Areas
Infectious Disease
Resources
Purchasing
Reference Material
Contact Us
Location
Corporate Headquarters
Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States
Telephone Numbers
Customer Service: (800) 227-6666 / (650) 697-3600
Contact Us
Additional Contact Details
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Quick Order
| Catalog Number | Size | Price |
|---|---|---|
| LS-G145914-100 | 100 µg | $1,070 |
Coronavirus SARS-CoV-2 Spike Glycoprotein (Recombinant 6His, C-terminus) (Ser686-Pro1213) - LS-G145914
Coronavirus SARS-CoV-2 Spike Glycoprotein (Recombinant 6His, C-terminus) (Ser686-Pro1213) - LS-G145914
Description:
SARS-CoV-2 Spike Glycoprotein LS-G145914 is a Recombinant Coronavirus SARS-CoV-2 Spike Glycoprotein produced in Baculovirus Ser686-Pro1213 with 6His, C-terminus tag(s). It is low in endotoxin; Less than 1.0 EU/µg protein (determined by LAL method).
Toll Free North America
(800) 227-6666
(800) 227-6666For Research Use Only
Overview
Description:
SARS-CoV-2 Spike Glycoprotein LS-G145914 is a Recombinant Coronavirus SARS-CoV-2 Spike Glycoprotein produced in Baculovirus Ser686-Pro1213 with 6His, C-terminus tag(s). It is low in endotoxin; Less than 1.0 EU/µg protein (determined by LAL method).
Specifications
Type
Recombinant Protein
Target
SARS-CoV-2 Spike Glycoprotein
Synonyms
S / Spike Glycoprote | SARS-CoV-2 | SARS-Cov2 | COVID-19 | SARS-CoV2 (COVID-19) Spike
Species
Coronavirus SARS-CoV-2
Modifications
Unmodified
Conjugations
Unconjugated
Tag
6His, C-terminus
Region
Ser686-Pro1213
Predicted Molecular Weight
59.37 kDa
Expression System
Baculovirus
Source Species
Insect
Purification
Greater than 90 % as determined by reducing SDS-PAGE.
Usage Summary
A DNA sequence encoding the 2019-nCoV Spike Protein S2 (ECD) (YP_009724390.1) (Ser686-Pro1213) was expressed with a polyhistidine tag at the C-terminus.
Bio-Activity
Not Tested
Endotoxin
Less than 1.0 EU/µg protein (determined by LAL method).
Presentation
Lyophilized from sterile 20 mM PB, pH 7.0, 300 mM NaCl, 10% Glycerol
Storage
Long term: store at -20°C to -80°C for up to Lyophilized store for up to 12 months. Reconstituted protein solution can be stored at 4-8°C for 2-7 days. Aliquots of reconstituted store at less than -20°C for 3 months
Restrictions
For research use only. Intended for use by laboratory professionals.
About SARS-CoV-2 Spike Glycoprotein
Publications (0)
Customer Reviews (0)
Images
Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis
Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis
Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis
Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 11/23/2024
Date Requested: 11/23/2024
